JHDAAI Legislative Testimony
As advocates for health equity and experts on marketplace and policy factors that impact drug pricing and access, JHDAAI faculty are often sought as expert sources for testimony in legislative chambers at the State and Federal levels. To connect with an expert about testifying, contact us.
- Federal Testimony
- State testimony
Federal Testimonies
Testimony by Gerard Anderson
| Before the House Committee on Energy and Commerce Subcommittee on Health on "Making Prescription Drugs More Affordable: Legislation to Negotiate a Better Deal for Americans" (September 25, 2019) | Website Link |
| Before the U.S. Senate Committee on Health, Education, Labor, and Pensions Hearing on "The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay" (June 13, 2017) | |
| BS. House Committee on Oversight & Government Reform Hearing on "Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain" (March 22, 2017) | PDF |
| Before the U.S. Senate Special Committee on Aging Hearing on "Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines" December 9, 2015 |
Testimony by Mariana Socal
| Before the House Education and Labor Committee / Subcommittee Hearing on "Making Health Care More Affordable: Lowering Drug Prices and Increasing Transparency" (September 26, 2019) | Website Link |
| Before the U.S. Food and Drug Administration on "The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products" (May 13, 2019) | Website Link Slides |
| Before the U.S. Food and Drug Administration on "Facilitating Price Competition and Innovation in the Biological Products Marketplace Public Hearing" (September 4, 2018) | Website Link |
State Testimonies
| Jeromie Ballreich Testimony for the Record Submitted to the Delaware Senate for Hearings on SB 176 (June 18, 2018) | |
| William Padula Testimony before the Health and Government Operations Committee, Maryland House of Delegates (February 23, 2017) | |
| Jeremy Greene Testimony before the Maryland Senate Finance Committee (February 15, 2017) | |
| G. Caleb Alexander Testimony before the Maryland Senate Finance Committee (January 24, 2017) |